Stock Market Today (LIVE): Micron's Post-Earnings Slide Continues; Markets Remain Volatile Amid Middle East Tensions
Mar 30, 2026 by Reuben Gregg BrewerAfter Crashing 45% in 180 Days, Is Bitcoin Still a Buy?Bitcoin is the leading cryptocurrency, and it has been falling hard; be careful if you're considering buying any.
Mar 30, 2026 by Reuben Gregg BrewerNvidia's Rubin Chip Arrives in Late 2026. Is Now the Time to Buy This Artificial Intelligence (AI) Stock?Nvidia is ready to launch its next-generation chip platform, but there are other factors to consider before you buy the stock.
Mar 30, 2026 by Daniel Sparks3 Beaten-Down Software Stocks: 2 to Avoid and 1 to BuyThese three software giants have all taken a hit this year, but only one looks like a buy.
Mar 30, 2026 by Reuben Gregg BrewerAfter Crashing 45% in 180 Days, Is Bitcoin Still a Buy?Bitcoin is the leading cryptocurrency, and it has been falling hard; be careful if you're considering buying any.
Mar 30, 2026 by Seena HassounaPresident Sells shares worth $1.0 Million at His Own DiscretionThis compliance software provider reported a notable insider sale, as direct holdings were reduced above the recent median pace.
Mar 30, 2026 by Reuben Gregg BrewerNvidia's Rubin Chip Arrives in Late 2026. Is Now the Time to Buy This Artificial Intelligence (AI) Stock?Nvidia is ready to launch its next-generation chip platform, but there are other factors to consider before you buy the stock.
Mar 30, 2026 by Daniel Sparks3 Beaten-Down Software Stocks: 2 to Avoid and 1 to BuyThese three software giants have all taken a hit this year, but only one looks like a buy.
Mar 30, 2026 by Daniel SparksAlphabet vs. Amazon: Both AI Stocks Have Been Hammered, but One Looks Like a Better Buy NowBoth tech giants have suffered in the recent market pullback, but one presents a more compelling artificial intelligence growth story today.
Mar 30, 2026 by David Jagielski, CPADoes This Impressive Chart Justify Palantir's High Valuation?Palantir's valuation is high, but so too is its growth rate.
Mar 30, 2026 by Seena HassounaCollegium's General Counsel Trims His Stake as the Company Doubles Down on ADHDThis specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and recent stock gains.
Mar 30, 2026 by Seena HassounaSionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another StoryThis biotech innovator in cystic fibrosis therapies reported a notable insider sale, as disclosed in recent SEC filings.
Mar 30, 2026 by David DierkingIs QQQ Still Worth Buying After the Market's Recent Slide?The Invesco QQQ ETF is 8% below its all-time high as I write this. Is this a good buying opportunity?
Mar 30, 2026 by Brett SchaferIs This the 1973 Oil Shock All Over Again? Here's How to Protect Your Portfolio.Oil prices are rising, but we are nowhere near the same levels as 1973.
Mar 30, 2026 by Seena HassounaAdaptive Biotech's President Trimmed Her Position. But what Remains is worth a lookAdaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale amid strong one-year stock gains.
Mar 30, 2026 by Daniel SparksHow Much Further Could Tesla Stock Fall?Even as the electric-car maker's operating margins are shrinking, the stock remains priced for perfection.
Mar 30, 2026 by Eric VolkmanWhy Red Cat Stock Was Dogged by the Bears TodayIt just announced its latest acquisition.
Mar 30, 2026 by Seena HassounaCLO Sells LGND 5,000 Shares for $1.0 MillionLigand Pharmaceuticals, a leader in drug licensing and royalties, reported a notable insider sale amid strong recent share performance.
Mar 30, 2026 by James BrumleyEveryone Is Rotating Out of Artificial Intelligence (AI) Stocks. Here's Why That Could Be a Costly Mistake in 2026.The comparison to the dot-com mania of the late 1990s, which came to a screeching halt in the early 2000s, is understandable, but it's ultimately misguided.
Mar 30, 2026 by Eric VolkmanWhy Avis Budget Group Stock Veered off Course MondayIt aims to float up to 5 million new shares of stock.
Mar 30, 2026 by Motley Fool YouTubeRegeneron Pharmaceuticals: A Strong Contender in the Biotech ArenaCould Regeneron Pharmaceuticals be the next big winner in biotech? Join us as we break down the company's strengths, challenges, and future potential in this insightful episode.
Mar 30, 2026 by David Jagielski, CPACan Gold Get Back Up to $5,000 This Year?Gold has been falling in recent weeks to levels not seen since January.
Mar 30, 2026 by Seena HassounaGulf Prtroleum Chief Lawyer's Holdings Have Shrunk 91% — Now He's Helping Run the CompanyOperating in the Utica Shale and SCOOP regions, this energy producer reported a notable insider sale amid ongoing portfolio adjustments.
Mar 30, 2026 by Emma NewberyStock Market Today, March 30: Micron Technology Falls on TurboQuant ShockToday, March 30, 2026, investors are weighing record AI-fueled growth against a new, memory-efficient algorithm.
